Experimental study on the effect of changes of myocardial collagen metabolism on the development of diabetic cardiomyopathy

丛丽,俞茂华,李益明,张秀荣,许祖德,杨琛
DOI: https://doi.org/10.3321/j.issn:1673-8225.2004.09.028
2004-01-01
Abstract:Aim: To observe the changes of myocardial collagen metabolism in streptozotocin (STZ) induced diabetic hamsters, and to enrich our understanding of the pathogenesis so as to provide a new idea for the therapy of diabetic cardiomyopathy. Methods: Diabetic hamster model was established by intraperitoneal injection (IP) of STZ 40 mg/kg once a day for 3 days. After stabilization of diabetic state for 10 weeks. Immunohistochemistry was used to measure expression levels of type I, and type III collagen in diabetic and normal hamster hearts. Activities of matrix metalloproteinase (MMPs) were detected by using gelatin zymography. Levels of blood glucose, glycated serum protein (GSP), lipoproteins and insulin were determined by using biochemical or radioimmunoassay methods. Results: Compared with the normal control group, the levels of blood glucose, GSP, triglycerides (TG), total cholesterol (CHO) and low density lipoprotein (LDL) in the diabetic group increased obviously. Levels of the expression of collagen I and III in the diabetic group (5.18 ± 0.86, 1.87 ± 0.28) were significantly higher than those in the control group (1.92 ± 0.27, 1.11 ± 0.12), ( t = -8.132, P < 0.001; t = -5.706, P < 0.01), and the expression of type I collagen was much higher in diabetic group. The activity of MMP-2 was higher in diabetic group (256.17 ± 31.32) % than in the control group (t = -11.150, P < 0.001). Conclusion: Diabetic cardiomyopathy hamster models can be established by intraperitoneal injection of STZ. Diabetic cardiomyopathy is manifested by deposition of myocardial collagen and activation of MMPs, and the inhibition of MMPs activity may have some therapeutic values.
What problem does this paper attempt to address?